Literature DB >> 9204614

Mortality associated with systemic candidiasis in children.

A Pacheco-Ríos1, C Avila-Figueroa, D Nobigrot-Kleinman, J I Santos.   

Abstract

The purpose of this study was to determine factors associated with an increased risk of mortality due to systemic Candida infections in children hospitalized at our tertiary care facility. A total of 71 cases of Candida bloodstream infections were identified over a 2-year period. The attack rate was 47 cases of candidemia per 10,000 discharges and the case fatality rate was 46.5%. Sixty-one cases occurred in infants under 2 years; 27 were newborns (38%). Using logistic regression analysis, we evaluated the independent effects of potential risk factors for death due to candidemia. Three factors were associated with the subsequent risk for death due to systemic candida infection: malnutrition (OR = 4.3; 95% CI 1.2-14.8), prior surgery (OR = 3.8; 95% CI 1.2-13.2), and the number of days between the first positive candida blood culture and the onset of antifungal treatment (OR = 1.12; 95% CI 1.06-1.25). Newborns showed an almost three times greater risk of death due to candidemia as compared to other age groups, but this association was only marginally significant (OR = 2.8; 95% CI 0.9-9.3). There was no difference in the rate of candidemia between the 2 years of the study; however, the observed mortality declined significantly from 65% in year one to 20% in year two (p = 0.02). The major finding of this study was to observe that for every day treatment was delayed the risk of death increased significantly. Thus, this study provides support for empirical antifungal therapy early in the course of suspected systemic candidiasis in order to improve survival among children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204614

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  8 in total

1.  Residual attributable mortality, a new concept for understanding the value of antibiotics in treating life-threatening acute infections.

Authors:  Richard P Wenzel; Chris Gennings
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

2.  Urinary D-arabinitol/L-arabinitol levels in infants undergoing long-term antibiotic therapy.

Authors:  Teresa J Stradomska; Bogumila Bobula-Milewska; Anna Bauer; Zbigniew Mielniczuk; Maria Dabkowska; Malgorzata Syczewska; Danuta Dzierzanowska
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  A 9-year study comparing risk factors and the outcome of paediatric and adults with nosocomial candidaemia.

Authors:  A C Pasqualotto; W L Nedel; T S Machado; L C Severo
Journal:  Mycopathologia       Date:  2005-09       Impact factor: 2.574

4.  Comparison of nosocomial candidemia of pediatric and adult cases in 2-years period at a Turkish university hospital.

Authors:  Asuman Birinci; Yeliz Tanriverdi Cayci; Kemal Bilgin; Murat Gunaydin; Cagatay Acuner; Saban Esen
Journal:  Eurasian J Med       Date:  2011-08

5.  Oral itraconazole in treatment of candidemia in a pediatric intensive care unit.

Authors:  Sunit C Singhi; Thimmapuram C S Reddy; Arunaloke Chakrabarti
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

Review 6.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 7.  Antifungal agents in neonates: issues and recommendations.

Authors:  Benito Almirante; Dolors Rodríguez
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 8.  Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome.

Authors:  Joanna Filioti; Kleomenis Spiroglou; Emmanuel Roilides
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.